Brief: NovaBay Pharmaceuticals To Acquire DERMAdoctor In $15 Mln Deal
Sept 28 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE
DERMADOCTOR
* NOVABAY PHARMACEUTICALS INC - OPERATIONAL SYNERGIES AND
DIVERSIFIED PRODUCT PORTFOLIO EXPECTED TO DRIVE PROFITABILITY
* NOVABAY PHARMACEUTICALS INC - ACQUISITION HAS POTENTIAL TO
DOUBLE TOPLINE REVENUE IN 2022
* NOVABAY PHARMACEUTICALS INC - DEAL FOR FOR A PURCHASE
PRICE OF
$15.0 MILLION,
Source text for Eikon: ID:nBw4V76Z6a
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing